Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Anika Therapeutics (ANIK) Shares Outstanding: 2010-2025

Historic Shares Outstanding for Anika Therapeutics (ANIK) over the last 8 years, with Sep 2025 value amounting to $14.4 million.

  • Anika Therapeutics' Shares Outstanding fell 1.86% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.4 million, marking a year-over-year decrease of 1.86%. This contributed to the annual value of $14.4 million for FY2024, which is 1.66% down from last year.
  • According to the latest figures from Q3 2025, Anika Therapeutics' Shares Outstanding is $14.4 million, which was up 0.02% from $14.4 million recorded in Q2 2025.
  • Over the past 5 years, Anika Therapeutics' Shares Outstanding peaked at $14.8 million during Q2 2024, and registered a low of $14,607 during Q3 2022.
  • Over the past 3 years, Anika Therapeutics' median Shares Outstanding value was $14.7 million (recorded in 2023), while the average stood at $14.6 million.
  • In the last 5 years, Anika Therapeutics' Shares Outstanding tumbled by 99.90% in 2022 and then skyrocketed by 100,105.38% in 2023.
  • Over the past 5 years, Anika Therapeutics' Shares Outstanding (Quarterly) stood at $14.4 million in 2021, then climbed by 1.27% to $14.6 million in 2022, then rose by 0.24% to $14.7 million in 2023, then decreased by 1.66% to $14.4 million in 2024, then fell by 1.86% to $14.4 million in 2025.
  • Its Shares Outstanding was $14.4 million in Q3 2025, compared to $14.4 million in Q2 2025 and $14.3 million in Q1 2025.